People

Randy Pritchard Joins Axena Health as CEO

Pritchard most recently served as CEO of Pillar Biosciences.

By: Michael Barbella

Managing Editor

There’s a new leader in charge at Axena Health Inc.

The female pelvic health firm has appointed Randy Pritchard as its CEO. Pritchard has nearly 25 years of experience in medical device and health technology, including leadership in driving commercial success, innovation, and strategic opportunities. His extensive background will help Axena Health improve the lives of women affected by pelvic floor disorders such as urinary incontinence (UI) and fecal incontinence (FI).

“We are excited to have Randy Pritchard leading Axena Health into its next phase of growth,” Axena Health Board Chairman Bret Christensen said. “Randy’s commercial acumen, operational expertise, and passion for improving patient outcomes make him the ideal leader to take Axena Health forward as we broaden access to its transformative pelvic health treatments for women.”

Pritchard joins Axena Health with a proven track record in strategic leadership and business expansion. He most recently served as CEO of Pillar Biosciences, a sequencing diagnostics company supporting cancer patients, where he led daily operations, secured funding, and drove top and bottom-line performance. He also worked as senior vice president of Marketing at Roche Diagnostics.

As CEO, Pritchard will oversee Axena Health’s operations and growth strategy, focusing on expanding access to the Leva Pelvic Health System, the company’s flagship product. The Leva System offers a non-invasive, medication-free UI and FI treatment. Pritchard will ensure Axena Health continues building partnerships, raises capital to support growth, and provides evidence-based, at-home, first-line treatments for female pelvic floor disorders.

“Randy has a strong history of leading innovative companies and delivering meaningful healthcare solutions. His proven ability to execute growth strategies and build a mission-driven culture aligns perfectly with Axena Health’s vision of changing the standard of care for female pelvic floor disorders,” Axena Health board member Shacey Petrovic stated.

In his new role, Pritchard will focus on refining the company’s strategic direction, improving insurance coverage for the Leva System, and driving operations across all functional areas, including sales and marketing and market access. He will also lead efforts to expand strategic partnerships within the women’s health space, while continuing to position the Leva System as the only prescription, at-home, first-line treatment for female UI and FI.

“I am thrilled to join Axena Health at this pivotal time,” Pritchard declared. “The company’s mission to transform women’s health with innovative, non-invasive treatments deeply resonates with me. I look forward to working with the company’s team to scale the business, continue product innovation, and improve access to effective solutions for pelvic floor disorders.”

The Leva Pelvic Health System offers a non-invasive, medication-free way for women to train and strengthen their pelvic floor muscles—at home in as little as five minutes a day—to treat UI and chronic FI. Combining a small U.S. Food and Drug Administration-cleared vaginal motion sensor with integrated software, the Leva System offers precise visualization of pelvic movement in real-time, enables progress tracking and allows active physician involvement. Recognizing that level-one evidence shows pelvic floor muscle training is most effective when performed under the supervision of a skilled healthcare provider, the Leva System is available by prescription only, allowing physicians the opportunity to treat UI and chronic FI on a broad scale. The Leva System has multiple clinical trials and published data from globally recognized medical centers supporting its efficacy in treating UI, including two studies in Obstetrics and Gynecology (The Green Journal).

Axena Health, Inc. aims to improve the lives of women with pelvic floor disorders. Its technology enables non-invasive, drug-free treatment through precise visualization of movement in real-time during pelvic floor muscle training, while monitoring usage and progress.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters